The Scientific Advisory Team at Allogene Therapeutics consists of distinguished experts who provide strategic scientific guidance and insights to advance the company’s research and development of allogeneic CAR T cell therapies. They collaborate with internal teams to ensure the scientific integrity of projects, identify new technological opportunities, and help navigate the latest advancements and challenges in cancer immunotherapy.
Donald B. Kohn
Scientific Advisor
Jae Park
Scientific Advisor
Malcolm K. Brenner
Scientific Advisor
Matthew Porteus
Scientific Advisor
Owen Witte
Scientific Advisor & Board Mem...
Stephan Grupp
Scientific Advisor
Stephen J. Forman
Scientific Advisor
Thomas F. Gajewski
Scientific Advisor
Ton Schumacher
Scientific Advisor
Wendell Lim
Scientific Advisor